S. Intaranongpai

Risk factors for melioidosis and bacteremic melioidosis.

Y. Suputtamongkol, W. Chaowagul, P. Mootsikapun, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Double-Blind Placebo-Controlled Study of an Infusion of Lexipafant (Platelet-Activating Factor Receptor Antagonist) in Patients with Severe Sepsis

J. Simpson, C. Permpikul, N. White, 2000, Antimicrobial Agents and Chemotherapy.

Antilipopolysaccharide II: an antibody protective against fatal melioidosis.

Y. Suputtamongkol, W. Chaowagul, D. Woods, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antagonist ) in Patients with Severe Sepsis ( Platelet-Activating Factor Receptor an Infusion of Lexipafant A Double-Blind Placebo-Controlled Study of

J. Simpson, C. Permpikul, N. White, 2000 .